Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1977; 37(03): 523-526
DOI: 10.1055/s-0038-1649261
DOI: 10.1055/s-0038-1649261
Original Article
Factor VIII Inhibitor Associated with Chlorpromazine-Induced Hepatic Injury
Further Information
Publication History
Received 14 October 1976
Accepted 08 January 1977
Publication Date:
03 July 2018 (online)
Summary
A 90-year-old man was given chlorpromazine for sedation and 2 weeks later developed cholestatic jaundice and subsequently a factor VIII inhibitor. His death 4 weeks after institution of chlorpromazine, from massive bleeding, coupled with the autopsy finding of intrahepatic cholestatic jaundice, suggests that both adverse reactions were due to the drug.
-
References
- 1 Biggs. (ed) Human Blood Coagulation, Haemostasis and Thrombosis . Oxford: Blackwell Scientific Publications; 1972
- 2 Canosa Jr. R. T, Hutton R. A, Deykin D. A chlorpromazine-induced inhibitor of blood coagulation (abstract). American Society of Hematology 1975; 18: 94
- 3 Childers Jr. R. T. Non-thrombocytopenic purpura in chlorpromazine therapy. Diseases of the Nervous System 1957; 18: 307
- 4 Denber H. C. D. Appraisal of drug reactions, correspondence. Journal of the American Medical Association 1955; 158: 586
- 5 Dubois E, Tallman E, Wonka R. A. Chlorpromazine-induced systemic lupus erythematosus. Journal of the American Medical Association 1972; 221: 595
- 6 Floch M, Leibowitz S. Hemorrhage from multiple sites associated with chlorpromazine-induced jaundice. Journal of the American Medical Association 1959; 170: 2060
- 7 Green D. Spontaneous inhibitors of factor VIII. British Journal of Haematology 1968; 15: 57
- 8 Ishak K. G, Irey N. S. Hepatic injury associated with the phenothiazines. Archives of Pathology 1972; 93: 283
- 9 Lechner K. Acquired inhibitors in non hemophilic patients. Hemostasis 1974; 3: 65
- 10 Marley E. Non-thrombocytopenic purpura after administration of chlorpromazine hydrochloride. British Medical Journal 1955; 2: 1126
- 11 Mullins J. F, Cohen I. M, Farrington E. S. Cutaneous sensitivity reactions to chlorpromazine. Journal of the American Medical Association 1956; 162: 946
- 12 Sherman L. A, Goldstein M. A, Sise H. S. Circulating anticoagulant (antifactor VIII) treated with immunosuppressive drugs. Thrombosis et Diathesis Haemorrhagica 1969; 21: 249
- 13 Waitzkin L. Hepatic dysfunction due to chlorpromazine hypersensitivity. Annals of Internal Medicine 1958; 49: 607